Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma.

Autor: Niitsu, Hikaru, Mizumoto, Masashi, Li, Yinuo, Nakamura, Masatoshi, Ishida, Toshiki, Iizumi, Takashi, Saito, Takashi, Numajiri, Haruko, Makishima, Hirokazu, Nakai, Kei, Oshiro, Yoshiko, Maruo, Kazushi, Sakurai, Hideyuki
Předmět:
Zdroj: Cancers; Jan2024, Vol. 16 Issue 2, p357, 12p
Abstrakt: Simple Summary: Radiation therapy for hepatocellular carcinoma is known to take time to shrink tumors. In recent years, there have been an increasing number of reports on proton beam therapy, but there are few reports on how tumors shrink after proton beam therapy. In this study, it was found that tumor shrinkage after proton beam therapy also takes time in hepatocellular carcinoma as in photon radiation therapy, with PR + CR rates of 57.5% at 1 year, 76.9% at 2 years, and 85.2% at 3 years. Moreover, in many cases, the tumor still shrinks after 1 year. Therefore, it is clear that at least one year of follow-up is necessary after irradiation to confirm the shrinkage effect of proton beam therapy for hepatocellular carcinoma. Background: Follow-up after treatment for hepatocellular carcinoma (HCC) can be mostly performed using dynamic CT or MRI, but there is no common evaluation method after radiation therapy. The purpose of this study is to examine factors involved in tumor reduction and local recurrence in patients with HCC treated with proton beam therapy (PBT) and to evaluate HCC shrinkage after PBT. Methods: Cases with only one irradiated lesion or those with two lesions irradiated simultaneously were included in this study. Pre- and post-treatment lesions were evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) by measuring the largest diameter. Results: The 6-, 12-, and 24-month CR + PR rates after PBT were 33.1%, 57.5%, and 76.9%, respectively, and the reduction rates were 25.1% in the first 6 months, 23.3% at 6–12 months, and 14.5% at 13–24 months. Cases that reached CR/PR at 6 and 12 months had improved OS compared to non-CR/non-PR cases. Conclusions: It is possible that a lesion that reached SD may subsequently transition to PR; it is reasonable to monitor progress with periodic imaging evaluations even after 1 year of treatment. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje